Should IDEXX’s (IDXX) SDMA-Enhanced Catalyst Panels Prompt Action From Long-Term Diagnostics Investors?
IDEXX Laboratories Inc IDXX
$559.37
▲ +1.14%
(+$6.30)
Index member:
S&P 500
NASDAQ-100
Open
$551.46
Prev Close
$553.07
Day Range
$549.75 – $562.30
52W Range
$496.61 – $769.98
Market Cap
$43.67B
P/E (TTM)
40.29
Beta
1.56
EPS (TTM)
$13.59
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1991-06-21 |
| Shares Out. | 78,880,000 |
| Website | idexx.com/ ↗ |
| Phone | 12075560300 |
IDEXX Laboratories Inc is a publicly traded company under the ticker symbol IDXX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
23 analysts (2026-05-01)
📰 Latest News for IDXX
IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles
Capitalizing On Growth Prospects, Irene Chang Britt Acquires IDEXX Laboratories Stock Options Worth $771
Bruce L Claflin Backs Up Beliefs With A Notable Acquisition Of IDEXX Laboratories Stock Options Worth $771
In A Strategic Move, Joseph L Hooley Acquires IDEXX Laboratories Stock Options Worth $771: Enhancing Value
Karen Peacock At IDEXX Laboratories Exercises Options Worth $0
Engaging In Insider Activity, Sam Samad At IDEXX Laboratories Exercises Options Worth $0
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day